PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23113953-0	2012	Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells.	Ambroxol	46-54	mucin 5AC, oligomeric mucus/gel-forming	Homo sapiens	58-64	
26881857-6	2016	The effect of ambroxol on the expression of mucoprotein 5 AC (MUC5AC) and proinflammatory cytokines in NCI-H292 cells stimulated with cigarette smoke extract (CSE).	Ambroxol	14-22	mucin 5AC, oligomeric mucus/gel-forming	Homo sapiens	44-60	
26881857-6	2016	The effect of ambroxol on the expression of mucoprotein 5 AC (MUC5AC) and proinflammatory cytokines in NCI-H292 cells stimulated with cigarette smoke extract (CSE).	Ambroxol	14-22	mucin 5AC, oligomeric mucus/gel-forming	Homo sapiens	62-68	
26872986-5	2016	Our results demonstrated that ambroxol administered by inhalation inhibited MUC5AC expression, reduced glycosaminoglycan levels, enhanced the function of mucociliary clearance and promoted sputum excretion, suggesting that ambroxol increases expectoration of sputum by reducing its viscosity.	Ambroxol	30-38	mucin 5AC, oligomeric mucus/gel-forming	Homo sapiens	76-82	
26872986-9	2016	In addition, we found that ambroxol dose-dependently inhibited LPS-induced increases in the mRNA expression of MUC5AC, TNF-alpha, and IL-1beta in human bronchial epithelial cell (NCI-H292) by inhibiting the Erk signaling pathway.	Ambroxol	27-35	mucin 5AC, oligomeric mucus/gel-forming	Homo sapiens	111-117